BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol

BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol

Abstract Background Prospective trials have demonstrated the advantage of dose-escalated radiotherapy for the biochemical and clinical control of intermediate risk prostate cancer. Dose escalation improves outcomes but increases risks of urinary and bowel toxicity. Recently the contribution of “spac...

Full description

Bibliographic Details
Main Authors: David Pasquier, Emilie Bogart, François Bonodeau, Thomas Lacornerie, Eric Lartigau, Igor Latorzeff
Format: Article
Language:English
Published: BMC 2018-05-01
Series:BMC Cancer
Subjects:
Implantable biodegradable balloon
Rectal spacer
Intensity modulated radiotherapy
Prostate cancer
Online Access:http://link.springer.com/article/10.1186/s12885-018-4492-5

Internet

http://link.springer.com/article/10.1186/s12885-018-4492-5

Similar Items